Skip to main content
Clinical Trials/CTRI/2018/05/013762
CTRI/2018/05/013762
Completed
Phase 2

Pre-clinical and clinical evaluation of safety and efficacy of a Siddha Herbo- Mineral formulation Nandhi Mezhugu in the treatment of Uthira Vatha Suronitham(Rheumatoid Arthritis) - SAESFNMIRA

AYOTHIDOSS PANDITHAR HOSPITA0 sites40 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: null- UTHIRAVATHASURONITHAM(RHEUMATOID ARTHRITIS)
Sponsor
AYOTHIDOSS PANDITHAR HOSPITA
Enrollment
40
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
September 14, 2016
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
AYOTHIDOSS PANDITHAR HOSPITA

Eligibility Criteria

Inclusion Criteria

  • 1\.Pain and swelling in smaller and major joints.
  • 2\.Symmetrical joint involvement.
  • 3\.More than 3 joints involved.
  • 5\.Morning stiffness.
  • 6\.Serum positive Anti CCP

Exclusion Criteria

  • 1\.Diabetes mellitus.
  • 2\.Hypo \& Hyperthyroidism.
  • 3\.Hypertension.
  • 4\.Cardiac disease.
  • 5\.Renal disease.
  • 6\.Liver disorder.
  • 7\.Neurological disorders.
  • 8\.Pregnancy and Lactation.
  • 9\.Alcoholism.
  • 10\.Recent treatment with steroids.

Outcomes

Primary Outcomes

Not specified

Similar Trials